How have OSIR shares performed in 2024?

Osiris Therapeutics' stock was trading at $18.99 on January 1st, 2024. Since then, OSIR stock has increased by 0.0% and is now trading at $18.99. View the best growth stocks for 2024 here .

What other stocks do shareholders of Osiris Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Osiris Therapeutics investors own include Sierra Wireless (SWIR) , Achillion Pharmaceuticals (ACHN) , Fate Therapeutics (FATE) , Ionis Pharmaceuticals (IONS) , Mallinckrodt (MNK) , Aerie Pharmaceuticals (AERI) , Cytokinetics (CYTK) and Depomed (DEPO) .

How do I buy shares of Osiris Therapeutics?

Shares of OSIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:OSIR

Osiris Therapeutics (OSIR) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free OSIR Stock Alerts

$18.99

0.00 (0.00%)

(As of 04/17/2019)

Compare

Today's Range: $18.99
▼
$18.99
50-Day Range: $18.99
▼
$18.99
52-Week Range: $7.01
▼
$19.30

Volume: N/A
Average Volume: 205,753 shs
Market Capitalization: $655.69 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Osiris Therapeutics alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Osiris Therapeutics Stock (OTCMKTS:OSIR)

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. The company also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds. It markets and distributes its products directly to physicians, hospitals, and other healthcare providers, as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

OSIR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OSIR Stock News Headlines

March 19, 2024 | fool.com

Kanak Kanti

February 18, 2024 | msn.com

MIT's Albumin-based cancer vaccine shows promising results in trials

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

February 2, 2024 | finance.yahoo.com

Tissue Engineering Market Set to Soar Past USD 32.45 Billion by 2030

January 19, 2024 | finance.yahoo.com

Anti-biofilm Wound Dressing Market Size & Share to Surpass US$ 2.3 Billion by 2030 - Exclusive Report by Persistence Market Research

December 29, 2023 | nypost.com

NASA launches mission to intercept ‘God of Chaos’ asteroid as it nears Earth’s orbit

December 11, 2023 | markets.businessinsider.com

ImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023

December 7, 2023 | msn.com

Ice Age ‘writing system’ to ‘zombie worm’ — 10 biggest science headlines of 2023

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

October 25, 2023 | finance.yahoo.com

UNION therapeutics to present at 7th Annual Dermatology Drug Development Summit in Boston

October 12, 2023 | uk.finance.yahoo.com

Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicated to its Genetic Medicine Delivery Platform

October 11, 2023 | finance.yahoo.com

Watch NASA reveal its Bennu asteroid samples at 11AM ET

October 6, 2023 | finance.yahoo.com

UNION therapeutics announces presentation of new data on orismilast at the EADV Congress 2023

September 28, 2023 | msn.com

Suspect shot by police on East Tabor Avenue in Fairfield

September 12, 2023 | bizjournals.com

10 companies selected as finalists for Coolest Thing Made in Colorado contest

September 12, 2023 | msn.com

Finalists announced for ‘Coolest Thing Made In Colorado’ competition

September 12, 2023 | msn.com

Finalists announced for ‘Coolest Thing Made In Colorado’

July 25, 2023 | finance.yahoo.com

Amniotic Membrane Global Market Report 2023

July 25, 2023 | benzinga.com

Regenerative Medicine Market to Grow Rapidly at a CAGR of 21.6% by 2030 | DataM Intelligence

June 23, 2023 | marketwatch.com

US Cell & Gene Therapy Market Report 2023-2028: Industry Expected to Grow at a CAGR of 41.25% - ResearchAndMarkets.com

June 16, 2023 | benzinga.com

Regenerative Medicine Market is expected to grow at a tremendous CAGR of 22.8% during the forecast period 2023-2030

May 30, 2023 | finance.yahoo.com

Tissue Engineering Global Market Report 2023

May 23, 2023 | finance.yahoo.com

Global Cell Therapy Market Report 2023: Growing Approvals for Cell-based Therapies Fuels the Sector

May 22, 2023 | markets.businessinsider.com

Vesselon Discovery Protects and Expands Drug Franchises

May 17, 2023 | marketwatch.com

Biological Derived Devices Market Reports, Scope, Methodology, Timelines And Challenges Forecast Till 2030

May 17, 2023 | marketwatch.com

Allogeneic Stem Cells Market Research Report Analysis the Regions, and International Markets Forecast (2023-2030)

May 17, 2023 | marketwatch.com

Global Stem Cells Market [2023-2030] | Growth Rate (CAGR) at a 10.9% | Expected to Reach Worth 5727.2

See More Headlines

Receive OSIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Osiris Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biological Products, Except Diagnostic
Sub-Industry: Biotechnology
Current Symbol: OTCMKTS:OSIR
Previous Symbol: NASDAQ:OSIR
CUSIP: 68827R10
CIK: 1360886
Web: www.osiristx.com
Phone: 443-545-1800
Fax: N/A
Employees: N/A
Year Founded: 1992

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 34,528,000
Free Float: N/A
Market Cap: $655.69 million
Optionable: Not Optionable
Beta: N/A

Social Links

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Jason Keefer (Age 46)
Interim Pres & CEO
Dr. Alla N. Danilkovitch (Age 54)
Chief Scientific Officer
Mr. Joel David Rogers (Age 56)
Interim Chief Financial Officer
Mr. Edward Yip
Chief Legal Officer & Corp. Sec.
Mr. Laine Dyess
VP of Sales

Key Competitors

View All Competitors

OSIR Stock Analysis - Frequently Asked Questions

How have OSIR shares performed in 2024?: Osiris Therapeutics' stock was trading at $18.99 on January 1st, 2024. Since then, OSIR stock has increased by 0.0% and is now trading at $18.99.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Osiris Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Osiris Therapeutics investors own include Sierra Wireless (SWIR), Achillion Pharmaceuticals (ACHN), Fate Therapeutics (FATE), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Aerie Pharmaceuticals (AERI), Cytokinetics (CYTK) and Depomed (DEPO).
How do I buy shares of Osiris Therapeutics?: Shares of OSIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:OSIR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Osiris Therapeutics (OSIR) Stock Price, News & Analysis

About Osiris Therapeutics Stock (OTCMKTS:OSIR)

OSIR Stock Price History

OSIR Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

OSIR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info